| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |